Tempest Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Revenue	0	0	0	0	0	0	0	0.65	0.28	0	Upgrade
Revenue Growth (YoY)	-	-	-	-	-	-	-	135.74%	-	-	Upgrade
Cost of Revenue	0	0	0	0	0	0	0	5.4	2.25	0	Upgrade
Gross Profit	0	0	0	0	0	0	0	-4.75	-1.97	0	Upgrade
Selling, General & Admin	11.66	12.11	9.82	4.91	17.56	12.45	5.96	49.22	51.59	26.15	Upgrade
Research & Development	17.5	22.53	17.17	14.39	27.84	14.43	14.53	21.64	18.43	21.78	Upgrade
Other Operating Expenses	0	0	0	0	0.21	0.17	63.84	5.4	0	0	Upgrade
Operating Expenses	29.16	34.64	26.99	19.3	45.61	27.04	84.33	76.26	70.03	47.93	Upgrade
Operating Income	-29.16	-34.64	-26.99	-19.3	-45.61	-27.04	-84.33	-81.01	-72	-47.93	Upgrade
Interest Expense / Income	1.45	1.62	1.28	-0.09	0	0	0.29	0	0	0	Upgrade
Other Expense / Income	-1.12	-0.55	0.03	-	-1.04	0.15	-0.04	1.05	1.15	1.59	Upgrade
Pretax Income	-29.49	-35.71	-28.3	-19.21	-44.57	-27.19	-84.58	-82.06	-73.14	-49.52	Upgrade
Income Tax	0	0	0	0	0	0	0	0.2	0.08	0	Upgrade
Net Income	-29.49	-35.71	-28.3	-19.21	-44.57	-27.19	-84.58	-82.26	-73.22	-49.52	Upgrade
Shares Outstanding (Basic)	15	12	4	0	1	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	15	12	4	0	1	0	0	0	0	0	Upgrade
Shares Change	33.49%	204.70%	709.62%	-48.77%	785.99%	-34.95%	10.97%	18.69%	19.60%	40.14%	Upgrade
EPS (Basic)	-1.91	-3.09	-7.47	-41.03	-48.75	-263.70	-533.40	-576.00	-607.50	-492.75	Upgrade
EPS (Diluted)	-1.91	-3.09	-7.47	-41.03	-48.75	-263.70	-533.40	-576.00	-607.50	-492.75	Upgrade
Free Cash Flow	-27.53	-31.63	-26.09	-19.07	-41.62	-23.68	-20.34	-64.32	-55.52	-33.39	Upgrade
Free Cash Flow Per Share	-1.79	-2.74	-6.88	-40.73	-45.55	-229.63	-128.31	-450.17	-461.17	-331.75	Upgrade
Gross Margin	-	-	-	-	-	-	-	-727.11%	-711.91%	-	Upgrade
Operating Margin	-	-	-	-	-	-	-	-12406.13%	-25992.42%	-	Upgrade
Profit Margin	-	-	-	-	-	-	-	-12597.24%	-26432.85%	-	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-	-	-9849.92%	-20041.52%	-	Upgrade
EBITDA	-25.96	-32.28	-25.75	-18.48	-43.52	-27.16	-84.26	-79.82	-71.86	-49.07	Upgrade
EBITDA Margin	-	-	-	-	-	-	-	-12223.74%	-25941.52%	-	Upgrade
Depreciation & Amortization	2.08	1.81	1.27	0.82	1.05	0.03	0.03	2.24	1.29	0.45	Upgrade
EBIT	-28.04	-34.09	-27.02	-19.3	-44.57	-27.19	-84.29	-82.06	-73.14	-49.52	Upgrade
EBIT Margin	-	-	-	-	-	-	-	-12566.46%	-26405.78%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).